FOXM1 and plasma cell myeloma: FOXM1-inhibiting antibiotics of this sort demonstrate broad cancer-suppressing activity in the low micromolar concentration range in solid and liquid tumors [21] – including myeloma (Fig. S8) – yet are not suitable for use in humans due to severe toxicity issues.